Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lockhart, A. C.
Right arrow Articles by Kim, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lockhart, A. C.
Right arrow Articles by Kim, R. B.
Related Collections
Right arrow Clinical Research
Right arrow Clinical Research: Clinical Pharmacology
Vol. 2, 685-698, July 2003     Molecular Cancer Therapeutics
© 2003 American Association for Cancer Research

Review

Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy1

A. Craig Lockhart, Rommel G. Tirona and Richard B. Kim2

Departments of Medicine and Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232

2 To whom requests for reprints should be addressed, at 572 RRB, 23rd Avenue at Pierce Avenue, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6602. Phone: (615) 343-1522; Fax: (615) 343-7605; E-mail: richard.kim{at}vanderbilt.edu

The ATP-binding cassette (ABC) transporters belong to the largest known transporter gene family and translocate a variety of substrates including chemotherapy agents. ABC multidrug transporter expression has been implicated in tumor cell resistance to anticancer therapy, altered disposition of chemotherapy drugs, and associated chemotherapy toxicity. More recently, genetic heterogeneity has been described in a number of the ABC transporter genes, including ABC transporters that contribute to the pharmacokinetics and/or pharmacodynamics of chemotherapy drugs. The role of these transporters and their naturally occurring genetic polymorphisms in cancer and chemotherapy is reviewed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.